Mental Health in Bladder Cancer Patients: Clinical Implications and Outcomes
Mental Health in Bladder Cancer Patients, impact of a bladder cancer diagnosis on risk of suicide, improving outcomes for patients with bladder cancer.
Related Articles
The Quickly Evolving Treatment Landscape of Metastatic Urothelial Carcinoma: A New Standard of Care in First-Line Systemic Therapy
bladder cancer, metastatic urothelial carcinoma, EV-302 trial, KEYNOTE-A39 study, enfortumab vedotin, pembrolizumab, enfortumab vedotin plus pembrolizumab, CheckMate 901 study, nivolumab plus gemcitabine/cisplatin, nivolumab, gemcitabine, antibody-drug…
Gemcitabine, Cisplatin and Immunotherapy: A Promising Mix for Advanced Bladder Cancer – Guru Sonpavde & Matthew Galsky
Guru Sonpavde and Matt Galsky delve into the CheckMate 901 study and its implications for advanced bladder cancer treatment. Dr. Sonpavde outlines the study’s design,…
Cretostimogene Grenadenorepvec Therapy Aims to Fill an Unmet Need in the Bladder Cancer Armamentarium – Robert Svatek
Zach Klaassen and Rob Svatek explore the potential of cretostimogene, a novel medication for non-muscle invasive bladder cancer. Dr. Svatek describes cretostimogene as an oncolytic…
The PCF Women in Science Forum: Empowering Female Researchers Through Networking and Mentorship – Veda Giri, Ayesha Shafi, & Claire Fletcher
Andrea Miyahira hosts a discussion with Veda Giri, Ayesha Shafi, and Claire Fletcher, members of the PCF Women in Science Forum Organizing Committee. The forum…
Nuclear Medicine Physician Discusses Career Path and Field Growth – Louise Emmett
Andrea Miyahira talks with Louise Emmett who shares her unconventional journey into nuclear medicine, sparked by a contrarian spirit and a suggestion against pursuing the…
Genetic Testing Reveals Treatment Opportunity and Disparity in Advanced Prostate Cancer – Colin Pritchard
Zach Klaassen engages with Colin Pritchard in a detailed discussion about genomic testing in prostate cancer. They emphasize the importance of genomic testing, particularly in…
CONTACT-02 Phase III Trial Findings on Cabozantinib-Atezolizumab Combination in mCRPC – Neeraj Agarwal
Alicia Morgans interviews Neeraj Agarwal about the CONTACT-02 trial, a phase III study that explores the combination of cabozantinib and atezolizumab in patients with metastatic…
Non-Metastatic CRPC in the Era of PSMA PET Imaging: Challenges and Opportunities – Aaron Berger
Zach Klaassen and Aaron Berger explore the evolving landscape of non-metastatic castration-resistant prostate cancer (CRPC). Dr. Berger highlights the decreasing frequency of non-metastatic CRPC in…
Novel Hormonal Therapies for High-Risk Biochemical Recurrence: the EMBARK Trial – Stephen Freedland
Daniel George and Stephen Freedland delve into the EMBARK study, a trial on Enzalutamide for high-risk non-metastatic biochemical recurrence of prostate cancer. They explore the…
Combination Maintenance Therapy for Advanced Bladder Cancer Explored in MAIN-CAV Study – Shilpa Gupta
Shilpa Gupta discusses the challenges and progress of the MAIN-CAV study examining the combination of treatments for urothelial cancer in the U.S., impacted by a…